Table 6 Adverse effects
| Â | Severity | |||||
|---|---|---|---|---|---|---|
Mild | Moderate | Severe | ||||
Adverse effects | Number | Number of patients (%) | Number | Number of patients (%) | Number | Number of patients (%) |
All | 3 | 2 (2.2) | 0 | 0 (0.0) | 0 | 0 (0.0) |
Myocardial injury | 1 | 1 (1.1) | 0 | 0 (0.0) | 0 | 0 (0.0) |
 Angina | 1 | 1 (1.1) | 0 | 0 (0.0) | 0 | 0 (0.0) |
General/systemic disorder and administration-site conditions | 1 | 1 (1.1) | 0 | 0 (0.0) | 0 | 0 (0.0) |
 Discomfort | 1 | 1 (1.1) | 0 | 0 (0.0) | 0 | 0 (0.0) |
Infection and parasitic disease | 1 | 1 (1.1) | 0 | 0 (0.0) | 0 | 0 (0.0) |
 Skin infection | 1 | 1 (1.1) | 0 | 0 (0.0) | 0 | 0 (0.0) |